大黄蛰虫丸联合醋酸亮丙瑞林治疗子宫内膜异位症的临床研究-现代医学

大黄蛰虫丸联合醋酸亮丙瑞林治疗子宫内膜异位症的临床研究

单位：1. 新疆维吾尔自治区妇幼保健院计划生育科, 新疆乌鲁木齐 830000;
2. 新疆维吾尔自治区妇幼保健院辅助生殖科, 新疆乌鲁木齐 830000

分类号：R711.71

出版年·卷·期（页码）：2018·46·第八期（901-906）

摘要：

目的：探讨大黄蛰虫丸联合醋酸亮丙瑞林治疗子宫内膜异位症的临床疗效。方法：选取我院收治的123例子宫内膜异位症腹腔镜术后患者作为研究对象，采用随机数字表法分为观察组、对照1组及对照2组，对照1组给予醋酸亮丙瑞林治疗，对照2组给予大黄蛰虫丸治疗，观察组则另口服给予大黄蛰虫丸联合醋酸亮丙瑞林治疗，所有患者均治疗28周。治疗结束后，评价3组患者疗效。治疗前及治疗28周后，观察3组患者生活质量评分，主要包括环境领域、社会关系领域、生理领域及生活领域评分。治疗前及治疗28周后，收集3组患者静脉血，检测其中性激素含量[黄体生成素（LH）、卵泡刺激素（FSH）及雌激素（E₂）]，子宫内膜异位症标记物含量[糖类抗原125（CA-125）、抗子宫内膜抗体（EMAb）及基质金属蛋白酶-3（MMP-3）]。治疗期间，密切观察患者的药物不良反应发生情况。结果：治疗后，观察组总有效率明显高于对照1组及对照2组（P<0.05）；治疗后，观察组环境领域、社会关系领域、生理领域及生活领域评分均明显高于对照1组及对照2组（P<0.05）；治疗后，观察组LH、FSH、E₂、CA-125、EMAb及MMP-3均明显低于对照1组及对照2组（P<0.05）。治疗期间，3组不良反应发生率基本一致（P>0.05）。结论：大黄蛰虫丸联合醋酸亮丙瑞林治疗子宫内膜异位症疗效确切，安全性较好，值得深入研究。

Objective:To explore the effect of dahuangzhechongwan pills combined with leuprorelin on endometriosis. Methods:123 cases of endometriosis patients afterlaparoscopy in our hospital were divided into the control group 1 (41 cases), control group 2 (41 cases) and observation group (41 cases). The control group 1 was treated with leuprorelin, control group 2 was treated with dahuangzhechongwan pills and the observation group was given dahuangzhechongwan pills and leuprorelin. The treatment time was 28 weeks. Before and 28 weeks after the treatment, the living quality scores (environmental scores, social scores, physical scores and life scores), sex hormone content (FSH, E₂ and LH) and endometriosis markers content (MMP-3, CA-125, EMAb) were observed in the 3 groups. During the treatment, the adverse actions were observed. Results:After the treatment, the total effective rate was significantly higher in the observation group than in the control group (P<0.05). After the treatment, the environmental scores, social scores, physical scores and life scores were significantly higher in the observation group than the control group 1 and the control group 2 (P<0.05), while the levels of MMP-3, CA-125, EMAb, IgG, FSH, E₂ and LH in the observation group were significantly lower than in the control group 1 and control group 2 (P<0.05). During the treatment, the rate of adverse reactions were similar in the 3 groups (P>0.05). Conclusion:Dahuangzhechongwan pills combined with leuprorelin in the treatment of endometriosis has a good clinical curative effect and safety, worthy of further study.

参考文献：

[1] BORRELI G M,ABRAO M S,TAUBE E T,et al.Immunohistochemical investigation of metastasis-related chemokines in deep-infiltrating endometriosis and compromised pelvic sentinel lymph nodes[J].Reprod Sci,2015,22(12):1632-1642.
[2] 欧蓉菁,郭英.子宫内膜异位症中西医发病机制的研究进展[J].新疆中医药,2015,33(1):63-66.
[3] 张艳,王夕梅.卵巢子宫内膜异位症恶变病因研究进展[J].医学综述,2015,21(1):59-61.
[4] SIKORA J,MIELCZAREK-PALACE A,KONDERA-ANASZ Z,et al.Peripheral blood proinflammatory response in women during menstrual cycle and endometriosis[J].Cytokine,2015,76(2):117-122.
[5] 李富娟.大黄蛰虫胶囊治疗子宫内膜异位症[J].中国实验方剂学杂志,2013,19(4):297-299.
[6] 金夏,周虎,桂云,等.醋酸亮丙瑞林缓释微球治疗子宫内膜异位症的疗效[J].中国妇幼保健,2012,27(19):2917-2920.
[7] 中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊断和治疗规范[J].中华妇产科杂志,2007,42(9):645.
[8] 郑筱萸.中药新药临床研究指导原则[S].北京:中国中医药科技出版社,2002:247.
[9] 李佳玲,赵艳霞,顾菁,等.基于项目反应理论修订生存质量测定量表简表WHOQOL-BREF[J].中山大学学报:医学科学版,2015,36(2):284-293.
[10] FACCHIN F,BARBARA G,SAITA E,et al.Impact of endometriosis on quality of life and mental health:pelvic pain makes the difference[J].J Psychosom Obstet Gynaecol,2015,36(4):135-141.
[11] 梁志清.子宫内膜异位症的腹腔镜手术[J].实用妇产科杂志,2002,18(2):74-76.
[12] 王梦梦,闫宏宇,韩璐.子宫内膜异位症临床治疗新进展[J].新疆中医药,2017,35(2):108-110.
[13] 马遇春,丛慧芳,王素,等.从伏邪理论探讨子宫内膜异位症的发病特点[J].辽宁中医杂志,2015,42(3):496-498.
[14] 乌云达来,萨仁高娃.大黄蛰虫丸临床研究进展[J].世界最新医学信息文摘:电子版,2016,97:70-71.
[15] 巩海涛,王雁群,贺广彬,等.大黄蛰虫丸抗栓作用及机理的研究[J].药学研究,2002,21(4):57-58.
[16] 张余芳,林尧,卢秀英,等.醋酸亮丙瑞林治疗子宫内膜异位症的临床观察[J].中国药房,2016,27(26):3675-3677.
[17] 沈栗帆,何艳,季菲,等.醋酸亮丙瑞林对子宫内膜异位症内分泌水平及骨密度的影响[J].新疆医科大学学报,2017,40(2):170-173.
[18] DAS S,BATRA S K.Understanding the unique attributes of MUC16(CA125):potential implications in targeted therapy[J].Cancer Res,2015,75(22):4669-4674.
[19] RICHARDS A,HERBST U,MANALANG J,et al.HE4,CA125,the risk of malignancy algorithm and the risk of malignancy index and complex pelvic masses-a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population[J].Aust N Z J Obstet Gynaecol,2015,55(5):493-497.
[20] 韩玉双,马凤英,孙晓燕.血清CA125、MMP-3及EMAb水平与子宫内膜异位症的相关性分析[J].医疗装备,2016,29(8):7-8.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录